PracticeUpdate Conference Series ISN WCN 2019

© 2017–2019 ISN WCD 2019 All rights reserved.

CONTENTS WCN 2019 • 12–15 April 2019 • Melbourne, Australia BY THE PRACTICEUPDATE EDITORIAL TEAM

4

12

18

3 Weight Gain and Obesity Post-Kidney Transplant Alarmingly High in Pediatric Population 4 CREDENCE Shows Safety and Efficacy of Canagliflozin for Renal Endpoints in Type 2 Diabetes 6 Cardiorenal Benefits of Empagliflozin Demonstrated in Proteinuric Diabetic Kidney Disease 7 Lower Dose Tacrolimus Remains Effective Immunosuppressive Strategy Following Kidney Transplant

8 Australian Study Demonstrates Benefits of Home Dialysis 9 ACTIVE Study Finds Extended Time on Dialysis Does Not Improve Survival 10 SONAR Study Reveals Potential for Atrasentan to Slow Kidney Disease Progression in Well-Selected Patients 12 Hemodiafiltration Offers Benefits Over Hemodialysis in Pediatric Setting 13 SGLT2 Inhibitors Benefit Patients With Diabetes and Chronic Kidney Disease 14 Global Kidney Health Atlas Reveals Worldwide Gaps in Care

16 Follow-Up Telehealth Service Saves Significant Money, Time for Kidney Transplant Patients 17 Kidney Disease Screening and Awareness Program Effectively Identifies Undetected Proteinuria 18 Undetected Community-Acquired Acute Kidney Injury Common in Low- Resource Settings 19 High BMI May Not Be Barrier to Successful Kidney Transplantation 20 Effects of Vitamin D Uncertain in Patients with Chronic Kidney Disease

The production of this publication is sponsored by Sanofi Genzyme. The provision of this information is not intended to advocate any use not covered by the Product Information. Please check that the product is approved for use and always consult the Product Information before prescribing.

1

WCN 2019 • PRACTICEUPDATE CONFERENCE SERIES